{
    "nctId": "NCT00510367",
    "briefTitle": "Primary Breast Cancer Occurring Concomitant With Pregnancy",
    "officialTitle": "Multimodality Treatment of Primary Breast Cancer Occurring Concomitant With Pregnancy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Pregnancy",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 61,
    "primaryOutcomeMeasure": "Response of Multimodality (Chemotherapy, Surgery and Radiation Therapy) Treatment of Primary Breast Cancer in Pregnant Participants",
    "eligibilityCriteria": "Inclusion Criteria:\n\n\u00b7 All patients with primary breast cancer occurring during pregnancy will be eligible for enrollment.\n\nExclusion Criteria:\n\n* Patients presenting with systemic metastases at time of diagnosis.\n* Patients unwilling or unable to give informed consent.\n* Patients who have received radiation therapy while pregnant\n* Patients who have received chemotherapy during the first trimester of pregnancy or chemotherapy other than FAC.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}